Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACXP | SABS | GOVX | ||
| Company | Acurx Pharmaceuticals Inc | Sab Biotherapeutics Inc | Geovax Labs | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.7300 | 3.10 | 2.50 | ||
| High | 1.7700 | 3.56 | 3.12 | ||
| Low | 1.6905 | 3.10 | 2.48 | ||
| Last | 1.7000 | 3.21 | 3.03 | ||
| Change | -0.0200 | +0.11 | +0.60 | ||
| % Change | -1.16% | +3.55% | +24.69% | ||
| Volume | 50,100 | 201,900 | 3,431,000 | ||
| 20-Day Average Volume | 37,735 | 82,465 | 3,673,085 | ||
| Previous Close | 1.7200 | 3.10 | 2.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8486 | 3.30 | 2.24 | ||
| 20-Day Raw Stochastic | 21.21% | 34.46% | 60.09% | ||
| 20-Day Relative Strength | 32.64% | 50.97% | 57.45% | ||
| Weighted Alpha | -50.99 | -62.86 | -87.57 | ||
| Today's Opinion | 100% Sell | 8% Buy | 8% Buy | ||
| Previous Opinion | 100% Sell | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 88% Sell | 48% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.61% since 11/11/24 | +0.63% since 11/11/24 | -3.50% since 11/11/24 | ||
| Low | 1.6300 on 11/15/24 | 3.10 on 11/18/24 | 2.31 on 11/13/24 | ||
| High | 1.8900 on 11/13/24 | 3.74 on 11/14/24 | 3.88 on 11/12/24 | ||
| 1-Month | |||||
| %Chg | -15.42% since 10/18/24 | +6.64% since 10/18/24 | +42.92% since 10/18/24 | ||
| Low | 1.6300 on 11/15/24 | 2.60 on 10/25/24 | 1.75 on 11/04/24 | ||
| High | 2.0200 on 10/21/24 | 4.37 on 11/04/24 | 3.88 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | -15.42% since 08/16/24 | +32.37% since 08/16/24 | -57.08% since 08/16/24 | ||
| Low | 1.6300 on 11/15/24 | 2.36 on 10/15/24 | 1.75 on 11/04/24 | ||
| High | 2.3900 on 08/22/24 | 4.37 on 11/04/24 | 11.18 on 08/19/24 | ||
| 6-Month | |||||
| %Chg | -24.44% since 05/17/24 | -11.57% since 05/17/24 | +78.24% since 05/17/24 | ||
| Low | 1.6300 on 11/15/24 | 2.16 on 08/14/24 | 1.09 on 06/18/24 | ||
| High | 3.3250 on 07/18/24 | 4.37 on 11/04/24 | 11.18 on 08/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,718 | 29,626 | 28,591 | ||
| Shares Outstanding, K | 16,893 | 9,229 | 9,436 | ||
| Annual Sales | 0 | 2,240,000 | 0 | ||
| Annual Net Income | -14,580,000 | -42,190,000 | -25,970,000 | ||
| Last Quarter Sales | 0 | 260,000 | 2,790,000 | ||
| Last Quarter Net Income | -2,820,000 | -7,340,000 | -5,820,000 | ||
| 60-Month Beta | -1.73 | 0.63 | 3.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 11/12/24 | -1.12 on 11/06/24 | -0.91 on 11/12/24 | ||
| Latest Earnings Date | 11/13/24 | 11/11/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||